These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11146231)

  • 1. DAP-5 is involved in MycN/IFNgamma-induced apoptosis in human neuroblastoma cells.
    Wittke I; Mädge B; Wiedemeyer R; Kimchi A; Schwab M
    Cancer Lett; 2001 Jan; 162(2):237-43. PubMed ID: 11146231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death.
    Levy-Strumpf N; Deiss LP; Berissi H; Kimchi A
    Mol Cell Biol; 1997 Mar; 17(3):1615-25. PubMed ID: 9032289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells.
    Lutz W; Fulda S; Jeremias I; Debatin KM; Schwab M
    Oncogene; 1998 Jul; 17(3):339-46. PubMed ID: 9690515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MycN sensitizes neuroblastoma cells for drug-triggered apoptosis.
    Fulda S; Lutz W; Schwab M; Debatin KM
    Med Pediatr Oncol; 2000 Dec; 35(6):582-4. PubMed ID: 11107122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.
    Levy-Strumpf N; Kimchi A
    Oncogene; 1998 Dec; 17(25):3331-40. PubMed ID: 9916995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity.
    Raveh T; Berissi H; Eisenstein M; Spivak T; Kimchi A
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1572-7. PubMed ID: 10677501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
    Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
    Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma-derived sulfhydryl oxidase, a new member of the sulfhydryl oxidase/Quiescin6 family, regulates sensitization to interferon gamma-induced cell death in human neuroblastoma cells.
    Wittke I; Wiedemeyer R; Pillmann A; Savelyeva L; Westermann F; Schwab M
    Cancer Res; 2003 Nov; 63(22):7742-52. PubMed ID: 14633699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.
    Norris MD; Bordow SB; Haber PS; Marshall GM; Kavallaris M; Madafiglio J; Cohn SL; Salwen H; Schmidt ML; Hipfner DR; Cole SP; Deeley RG; Haber M
    Eur J Cancer; 1997 Oct; 33(12):1911-6. PubMed ID: 9516823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.
    Cortés C; Kozma SC; Tauler A; Ambrosio S
    Cell Oncol (Dordr); 2015 Oct; 38(5):341-52. PubMed ID: 26306783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
    Teitz T; Wei T; Liu D; Valentine V; Valentine M; Grenet J; Lahti JM; Kidd VJ
    Oncogene; 2002 Mar; 21(12):1848-58. PubMed ID: 11896617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
    Chen Y; Tsai YH; Tseng SH
    Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation.
    Puppo M; Pastorino S; Melillo G; Pezzolo A; Varesio L; Bosco MC
    Clin Cancer Res; 2004 Dec; 10(24):8704-19. PubMed ID: 15623656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
    Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
    Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.
    Chen Y; Stallings RL
    Cancer Res; 2007 Feb; 67(3):976-83. PubMed ID: 17283129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
    Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
    Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tetracycline-controlled antisense bcl-2 expression on the growth and apoptosis of human neuroblastoma cell line SK-N-MC.
    Guan J; Chen J; Zhao H
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):135-9. PubMed ID: 12419161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.
    Duffy DJ; Krstic A; Halasz M; Schwarzl T; Fey D; Iljin K; Mehta JP; Killick K; Whilde J; Turriziani B; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
    Oncotarget; 2015 Dec; 6(41):43182-201. PubMed ID: 26673823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.